- Product Details
Keywords
- Nilotinib
- Nilotinib 98
- Nilotinib(AMN 107)
Quick Details
- ProName: Nilotinib
- CasNo: 641571-10-0
- Molecular Formula: C28H22F3N7O
- Appearance: as description
- Application: Pharmaceutical intermediates
- DeliveryTime: Within 5-7 work days after confirming ...
- PackAge: 100g, 1kg
- Port: Shanghai
- ProductionCapacity: 100 Kilogram/Month
- Purity: 98%
- Storage: cool and dry
- Transportation: by air
- LimitNum: 100 Gram
- Moisture Content: <0.5%
- Impurity: <1%
Superiority
Shanghai, Run-Biotech Co., Ltd is a leading domestic pharmaceutical, biopharmaceutical, and health care products R & D outsourcing services company. As an innovation-driven and customer-focused company, Run Biotech provides a broad and integrated portfolio of services throughout the drug R&D process. Our services are designed to help our worldwide customers shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient outsourcing solutions.
Based on our technical expertise and excellent research facilities, we successfully establish facilities, advanced R & D services technology platform. We will achieve leapfrog all-round development in the field of chemical synthesis, medicinal chemistry, biological and so on.
Run Biotech has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, discovery biology, pharmacology, formulation services, biologics manufacturing services, antibody, biological research reagent manufacturing and sales services.
In Taiwan , Mainland China and Southeast Asia, Run Biotech has its own logistics center, provides the professional, personalized one-stop services, offers a variety of technologies and products and services for the world's major technology and industrial customers.
Details
Product Name: | Nilotinib |
Synonyms: | Nilotinib(AMN 107);Nilotinib, AMN107, Tasigna;Nilotinib-d6;4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-phenyl)-3-((4-(pyridin-3-yl)pyrimid;Nilotinib &aMp;4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide Nilotinib (AMN-107);Nilotinib 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide;Nilotinib, >=99% |
CAS: | 641571-10-0 |
MF: | C28H22F3N7O |
MW: | 529.52 |
EINECS: | 700-544-5 |
Product Categories: | AMN-107;Cardiovascular APIs;-;Inhibitors;API;Molecular Targeted Antineoplastic;Nucleotides and Nucleosides;Bases & Related Reagents;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals;Pharmaceutical intermediate |